GLP-1 ANALOGS FOR NEUROPROTECTION AFTER OUT-OF-HOSPITAL CARDIAC ARREST, A RANDOMIZED CLINICAL TRIAL

Trial Profile

GLP-1 ANALOGS FOR NEUROPROTECTION AFTER OUT-OF-HOSPITAL CARDIAC ARREST, A RANDOMIZED CLINICAL TRIAL

Completed
Phase of Trial: Phase III

Latest Information Update: 16 Nov 2016

At a glance

  • Drugs Exenatide (Primary) ; Albumin human
  • Indications Neurological disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 16 Nov 2016 Results presented at the 89th Annual Scientific Sessions of the American Heart Association
    • 12 Nov 2016 Primary endpoint has not been met. (Efficacy assessed by Area under the Neuron-specific Enolase curve)
    • 12 Nov 2016 Results published in the Circulation
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top